Streetbeat News

Price Targets

GDEN

JMP Securities analyst Jordan Bender maintains a Market Outperform rating on Golden Entertainment (NASDAQ:GDEN) but lowers the price target from $56 to $51.

Portfolio Pulse from jenniferd'souza@benzinga.com

August 01, 2023 | 12:16 pm

IMGN

BMO Capital analyst Etzer Darout maintains an Outperform rating on Immunogen (NASDAQ:IMGN) and raises the price target from $25 to $26.

Portfolio Pulse from richadhand@benzinga.com

August 01, 2023 | 12:14 pm

FBIN

BMO Capital analyst Ketan Mamtora maintains an 'Outperform' rating on Fortune Brands (NYSE:FBIN) and raises the price target from $82 to $84.

Portfolio Pulse from richadhand@benzinga.com

August 01, 2023 | 12:13 pm

DV

JMP Securities analyst Andrew Boone maintains a Market Outperform rating on DoubleVerify Hldgs (NYSE:DV) but has lowered the price target from $45 to $43.

Portfolio Pulse from jenniferd'souza@benzinga.com

August 01, 2023 | 12:13 pm

AZN

BMO Capital analyst Etzer Darout has maintained an Outperform rating on AstraZeneca (NASDAQ:AZN) and raised the price target from $81 to $83.

Portfolio Pulse from richadhand@benzinga.com

August 01, 2023 | 12:12 pm

TSX:ATH

BMO Capital analyst Mike Murphy has maintained a 'Market Perform' rating on Athabasca Oil (TSX:ATH) and raised the price target from C$3.75 to C$4.

Portfolio Pulse from richadhand@benzinga.com

August 01, 2023 | 12:12 pm

AEO

AJG

ANET

COIN

EL

F

GS

MPWR

RH

SILC

WFC

Several analyst forecasts were released on Tuesday, with price target changes for Silicom Ltd., Arista Networks, Arthur J. Gallagher & Co., American Eagle Outfitters, Coinbase Global, RH, The Goldman Sachs Group, The Estée Lauder Companies, Monolithic Power Systems, Wells Fargo & Company, and Ford Motor Company. Most of the companies saw their price targets raised, with the exception of Silicom and The Estée Lauder Companies, which saw their targets cut.

Portfolio Pulse from Lisa Levin

August 01, 2023 | 12:08 pm

VLY

Hovde Group analyst David Bishop has downgraded Valley Ntl (NASDAQ:VLY) from Outperform to Market Perform and set a price target of $11.

Portfolio Pulse from richadhand@benzinga.com

August 01, 2023 | 12:03 pm

RETA

Citigroup analyst Yigal Nochomovitz has downgraded Reata Pharmaceuticals from Buy to Neutral, while raising the price target from $127 to $172.5.

Portfolio Pulse from richadhand@benzinga.com

August 01, 2023 | 12:01 pm

MXL

Loop Capital analyst Ananda Baruah has downgraded MaxLinear (NASDAQ:MXL) from Buy to Hold and set a price target of $25.

Portfolio Pulse from richadhand@benzinga.com

August 01, 2023 | 12:00 pm